23andMe Rides Again: FDA Clears Genetic Tests To Predict Disease Risk

23andMe, a genetic testing startup that captured the national imagination a decade ago, appears to have fully emerged from the wilderness.┬áThe Food and Drug Administration has cleared the startup to market $199 genetic tests that will tell consumers not whether they have a condition like Parkinson’s or Alzheimer’s, but how likely they might be to […]

Read more "23andMe Rides Again: FDA Clears Genetic Tests To Predict Disease Risk"